Judge Lifts Injunction On Drug Maker

Law360, New York (March 7, 2007, 12:00 AM EST) -- The judge overseeing Dusa Pharmaceuticals Inc.’s patent infringement suit against River’s Edge Pharmaceuticals LLC has lifted a preliminary injunction that barred a competitor from entering the market for Dusa acne treatment Nicomide.

On Wednesday, U.S. District Judge Stanley R. Chesler filed an order dissolving the injunction and granting a motion by River’s Edge that called the validity of the patent asserted by Dusa into question.

At issue in the suit is U.S. Patent Number 6,979,468, which covers an oral treatment of inflammatory skin disorders comprising nicotinamide...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.